Sagris, D.; Florentin, M.; Tasoudis, P.; Korompoki, E.; Gatselis, N.; Giamarellos-Bourboulis, E.J.; Milionis, H.; Douketis, J.; Spyropoulos, A.C.; Dalekos, G.;
et al. Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials. J. Clin. Med. 2021, 10, 5366.
https://doi.org/10.3390/jcm10225366
AMA Style
Sagris D, Florentin M, Tasoudis P, Korompoki E, Gatselis N, Giamarellos-Bourboulis EJ, Milionis H, Douketis J, Spyropoulos AC, Dalekos G,
et al. Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials. Journal of Clinical Medicine. 2021; 10(22):5366.
https://doi.org/10.3390/jcm10225366
Chicago/Turabian Style
Sagris, Dimitrios, Matilda Florentin, Panagiotis Tasoudis, Eleni Korompoki, Nikolaos Gatselis, Evangelos J. Giamarellos-Bourboulis, Haralampos Milionis, James Douketis, Alex C. Spyropoulos, George Dalekos,
and et al. 2021. "Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials" Journal of Clinical Medicine 10, no. 22: 5366.
https://doi.org/10.3390/jcm10225366
APA Style
Sagris, D., Florentin, M., Tasoudis, P., Korompoki, E., Gatselis, N., Giamarellos-Bourboulis, E. J., Milionis, H., Douketis, J., Spyropoulos, A. C., Dalekos, G., & Ntaios, G.
(2021). Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials. Journal of Clinical Medicine, 10(22), 5366.
https://doi.org/10.3390/jcm10225366